Abstract:Background: Brain tumors present a complex challenge in clinical oncology, where precise diagnosis and classification are pivotal for effective treatment planning. Radiomics, a burgeoning field in neuro-oncology, involves extracting and analyzing numerous quantitative features from medical images. This approach captures subtle spatial and textural information imperceptible to the human eye. However, implementation in clinical practice is still distant, and concerns have been raised regarding the methodological quality of radiomic studies. Methodology: A systematic literature search was performed to identify original articles focused on the use of radiomics for brain tumors from 2015 based on the inclusion and exclusion criteria. The radiomic features train machine learning models for glioma classification, and data are split into training and testing subsets to validate the model accuracy, reliability, and generalizability. The present study systematically reviews the status of radiomic studies concerning brain tumors, also using the radiomics quality score (RQS) to assess the quality of the methodology used in each study. Results: A systematic search of PubMed identified 300 articles, with 18 studies meeting the inclusion criteria for qualitative synthesis. These studies collectively demonstrate the potential of radiomics-based machine learning models in accurately distinguishing between glioma subtypes and grades. Various imaging modalities, including MRI, PET/CT, and advanced techniques like ASL and DTI, were utilized to extract radiomic features for analysis. Machine learning algorithms such as deep learning networks, support vector machines, random forests, and logistic regression were applied to develop predictive models. Conclusions: The present study indicates high accuracies in glioma classification, outperforming traditional imaging methods and inexperienced radiologists in some cases. Further validation and standardization efforts are warranted to facilitate the clinical integration of radiomics into routine practice, ultimately enhancing glioma management and patient outcomes. Open science practices: Machine learning using MRI radiomic features provides a simple, noninvasive, and cost-effective method for glioma classification, enhancing transparency, reproducibility, and collaboration within the scientific community.

Current Advances and Challenges in Radiomics of Brain Tumors

Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches

Radiomics in the precision diagnosis and treatment of brain tumor:the application and challenge

The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges

Radiomics in breast cancer: Current advances and future directions

Radiomics and Machine Learning in Brain Tumors and Their Habitat: A Systematic Review

Radiomics in gliomas: A promising assistance  for glioma clinical research.

[Radiomics: the process and applications in tumor research].

Radiomics in radiation oncology—basics, methods, and limitations

Artificial intelligence in the radiomic analysis of glioblastomas: A review, taxonomy, and perspective

Radiomics as an emerging tool in the management of brain metastases

SS-2 Current status and future perspective of radiomics in glioma imaging

Progress in research and application of Radiomics

Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation

The current state of MRI-based radiomics in pituitary adenoma: promising but challenging

Medical imaging in tumor precision medicine: opportunities and challenges

Quality Assessment of MRI-Radiomics-Based Machine Learning Methods in Classification of Brain Tumors: Systematic Review

The Current State of Radiomics for Meningiomas: Promises and Challenges

Current Status and Quality of Radiomics Studies in Lymphoma: a Systematic Review

Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential

Radiomics: the process and the challenges